Showing results (301-310 of 39,526) with videos related to

Sort By:
Pageof 3,953
Blood|September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemiaTina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Blood|October 1, 2025
Fetal context conveys heritable protection against MLL-rearranged AML that depends on MLL3Jonny Mendoza-Castrejon, Wei Yang, Elisabeth Denby, et al.
Blood|September 22, 2025
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 studyAjai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria, et al.
Blood|September 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencingAnaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, et al.
Blood|January 1, 1988
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)W S Velasquez, F Cabanillas, P Salvador, et al.
Blood|January 1, 1988
Cultured human umbilical vein endothelial cells contain a membrane glycoprotein immunologically related to platelet glycoprotein IbJ D Sprandio, S S Shapiro, P Thiagarajan, et al.
Blood|January 1, 1988
The effect of deoxygenation rate on the formation of irreversibly sickled cellsK Horiuchi, S K Ballas, T Asakura
Blood|December 28, 2019
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHDClint Piper, Vivian Zhou, Richard Komorowski, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Blood|December 27, 2019
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML studySimona Soverini, Luana Bavaro, Caterina De Benedittis, et al.
Pageof 3,953